RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
  Bladder
  Blood
  Bone Cancer
  Brain
  Breast Cancer
  Carcinogens
  Cervical Cancer
  Colon
  Endometrial
  Esophageal
  Gastric Cancer
  Liver Cancer
  Lung
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Skin
  Testicular Cancer
  Therapy
  Thyroid
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
107th American Roentgen Ray Society Annual Meeting Liver Cancer Channel

subscribe to Liver Cancer newsletter
Latest Research : Cancer : Liver Cancer

   EMAIL   |   PRINT
Percutaneous radiofrequency ablation of liver tumors prove safe and effective

May 5, 2007 - 2:14:26 AM , Reviewed by: Dr. Rashmi Yadav

 
Main results
"Our study further revealed an interesting finding in that the approaches used for ablation do not affect the effectiveness of the ablation treatment."
[RxPG]
Percutaneous radiofrequency ablation of liver tumors prove safe and effective
The study showed that the percutaneous approach is better tolerated by the patients, with significantly less post-procedural pain.
Percutaneous imaging guided radiofrequency ablation (RFA) of hepatocellular carcinoma is a safe and effective technique, with benefits such as reduced post-procedural pain and length of hospital stay, according to a study conducted by researchers from Changi General Hospital in Singapore.

Radiofrequency ablation of a liver tumor may be performed in a number of ways, said Hui Seong Teh, MD, lead author of the study. Two commonly used techniques are the percutaneous approach and open surgery. There have been few studies that compare the efficacy of the two methods, Dr. Teh says.

The study showed that the percutaneous approach is better tolerated by the patients, with significantly less post-procedural pain. Based on an objective scoring system, average pain score was 0.1 for patients who underwent the percutaneous technique, compared to 1.4 for those who had ablation performed with open laprotomy. Patients also have a much shorter stay in the hospital if they were treated using the percutaneous method, Dr. Teh says. The average length of stay in hospital was 2 days for patients who had the percutaneous method, compared to 10 days for those who had open RFA. The shorter length of hospital stay allows patients to resume their activity of daily living faster and enable their early return to active economy, says Dr. Teh.

"Our study further revealed an interesting finding in that the approaches used for ablation do not affect the effectiveness of the ablation treatment," Dr. Teh added. "The choice of RFA methods will affect the hospital resources spent on these patients, and will have a significant impact on healthcare cost," he said.

The full results of this study will be presented on Wednesday, May 9, 2007 during the American Roentgen Ray Society’s annual meeting in Orlando, FL.



Publication: 107th American Roentgen Ray Society Annual Meeting
On the web: http://www.arrs.org/ 

Advertise in this space for $10 per month. Contact us today.


Related Liver Cancer News
Thalidomide may help as adjuvant therapy for hepatocellular carcinoma
Chlorophyll limits the absorption of the carcinogen aflatoxin
Sunitinib slows tumor growth and metastasis in hepatocellular carcinoma
Combined stenting and photodynamic therapy may improve survival rates in liver cancer
Percutaneous radiofrequency ablation of liver tumors prove safe and effective
Cancer cells metastatic to the liver are a perfect target for gene therapy, study reports
Nexavar shown to significantly extend survival for patients with advanced liver cancer
Colchicine can delay the development of hepatocellular carcinoma
Study implicates two human genes in liver cancer
Skin rash after lapatinib for liver cancer determines survival

Subscribe to Liver Cancer Newsletter

Enter your email address:


 About Dr. Rashmi Yadav
This news story has been reviewed by Dr. Rashmi Yadav before its publication on RxPG News website. Dr. Rashmi Yadav, MBBS, is a senior editor for RxPG News. In her position she is responsible for managing special correspondents and the surgery section of the website. Her areas of special interest include cardiothoracic surgery and interventional radiology.
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)